These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 596695)

  • 1. Feline interferon response to 2-amino-5-bromo-6-methyl-4-pyrimidinol (U-25,166).
    Stringfellow DA; Weed Sd
    Am J Vet Res; 1977 Dec; 38(12):1963-7. PubMed ID: 596695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of murine interferon by a substituted pyrimidine.
    Nichol FR; Weed SD; Underwood GE
    Antimicrob Agents Chemother; 1976 Mar; 9(3):433-9. PubMed ID: 176934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The reduction of voluntary physical activity after poly I:C injection is independent of the effect of poly I:C-induced interferon-beta in mice.
    Matsumoto T; Takahashi H; Shiva D; Kawanishi N; Kremenik MJ; Kato Y; Yano H
    Physiol Behav; 2008 Mar; 93(4-5):835-41. PubMed ID: 18191426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparation interferon- inducing and antiviral properties of 2-amino-5-bromo-6-methyl-4-pyrimidinol (U-25,166), tilorone hydrochloride, and polyinosinic-polycytidylic acid.
    Stringfellow DA
    Antimicrob Agents Chemother; 1977 Jun; 11(6):984-92. PubMed ID: 879763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between circulating interferon and drug levels following administration of 2-amino-5-bromo-6-phenyl-4(3H)-pyrimidinone (ABPP) to different animal species.
    Hamilton RD; Wynalda MA; Fitzpatrick FA; Teagarden DL; Hamdy AH; Snider BG; Weed SD; Stringfellow DA
    J Interferon Res; 1982; 2(3):317-27. PubMed ID: 6182250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic responses in healthy random-source cats fed N,N-dimethylglycine-supplemented diets.
    Weiss RC
    Am J Vet Res; 1992 May; 53(5):829-33. PubMed ID: 1381880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of acid-stable canine interferon in vivo and in vitro.
    Forman MS; Adams EW; Vanderpool EA; Turner W
    Am J Vet Res; 1979 Oct; 40(10):1440-2. PubMed ID: 43104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of interferon induction in mice by polycationic modified polypeptides.
    Mécs I; Gánti T; Kótai A
    Acta Virol; 1976 Apr; 20(2):164-6. PubMed ID: 5874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of tumor growth rate by interferon inducers.
    Gazdar AF
    J Natl Cancer Inst; 1972 Nov; 49(5):1435-8. PubMed ID: 4346539
    [No Abstract]   [Full Text] [Related]  

  • 11. Interferon induction by and toxicity of polyriboinosinic acid [poly(rI)].polyribocytidylic acid [poly (rC)], mismatched analog poly (rI).poly[r(C12Uracil)n], and poly(rI).poly(rC) L-lysine complexed with carboxymethylcellulose.
    Stringfellow DA; Weed SD
    Antimicrob Agents Chemother; 1980 Jun; 17(6):988-92. PubMed ID: 6157363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-hyporesponsiveness in mice in connection with dose interval and site of administration of Newcastle disease virus. Reflexion in serum complement levels.
    Rathová V; Kocisková D; Borecký L
    Acta Virol; 1975 Apr; 19(2):158-61. PubMed ID: 239563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction and properties of guinea pig serum interferon. Preliminary report.
    Nolewajka E; Mikolajski K; Kapp-Burzyńska Z; Trzeciak J; Wrona M
    Arch Immunol Ther Exp (Warsz); 1977; 25(5):623-5. PubMed ID: 597011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic and metabolic studies on the priming effect of interferon in L cells.
    Rosztóczy I
    Arch Immunol Ther Exp (Warsz); 1977; 25(5):631-9. PubMed ID: 597012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of resistance to Listeria monocytogenes infection in mice by pyrimidine analogs.
    Anthony LS; Stevenson MM; Skamene E
    Clin Invest Med; 1984; 7(4):343-8. PubMed ID: 6532636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of interferon on thoracic duct lymphocyte output: induction with either poly I:poly C or vaccinia virus.
    Korngold R; Blank KJ; Murasko DM
    J Immunol; 1983 May; 130(5):2236-40. PubMed ID: 6187846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related production of spotted souslik (Spermophilus suslicus) interferon.
    Kandefer-Szerszeń M
    Arch Immunol Ther Exp (Warsz); 1988; 36(4):453-8. PubMed ID: 2471479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of interferon production in a mouse model of thermal injury.
    Suzuki F; Pollard RB
    J Immunol; 1982 Nov; 129(5):1806-10. PubMed ID: 6181145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of feline interferon-omega after ocular or oral administration in cats as indicated by Mx protein expression in conjunctival and white blood cells.
    Bracklein T; Theise S; Metzler A; Spiess BM; Richter M
    Am J Vet Res; 2006 Jun; 67(6):1025-32. PubMed ID: 16740097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects on interferon of heavy metal excess and zinc deficiency.
    Gainer JH
    Am J Vet Res; 1977 Jun; 38(6):863-7. PubMed ID: 195499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.